Navigation Links
Long-term use of calcium supplements to prevent colon cancer,,

Scientists of Dartmouth Medical School said that intake of calcium supplements over the years can act as a preventive measure for people at risk of colon cancer.//

Calcium supplements can reduce about 36% of the chances of pre-cancerous polyp formations in colon. Calcium has chemo protective properties that can prevent formation of colorectal polyps.

The previous study was in a trial, which observed 930 patients with a history of developing pre-cancerous adenoma, and was given 1200 mg. of calcium supplements or placebo medications daily. The results had showed that calcium supplements had been able reduce overall polyp formation by 19% in people.

New study had now showed that of 822 of the original subjects of the previous study, follow up colonoscopies were performed on 597 participants. After adjusting for the use to calcium supplements in the preceding study, there had been a reduction of 36% in the growth of new adenoma polyps in those subjects who had continued the use of supplementary calcium. There was a 40% reduction of risks against the development of non-neoplastic hyperplastic polyps in those subjects as well.

However researchers had found out that this protective effect of calcium reduces over time.

Reference: 96th Annual Meeting of the American Association for Cancer Research, Press Release
'"/>




Page: 1

Related medicine news :

1. Long-term Care Should Be A Planned Affair
2. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
3. Global AIDS Conference Calls for Long-term Strategies
4. Long-term Use of Stomach Drugs may Weaken Bones
5. Asthma Sufferers Favor Quick Relief Over Long-term Control
6. Long-term Marijuana Smoking Leads to Respiratory Complaints
7. Tamoxifen Yields Long-term Reduction in Breast Cancer Risk
8. Vitamin D, calcium don’t prevent fractures in elderl
9. Eating food rich in calcium and vitamin D helps fight PMS
10. Never undermine the importance of calcium and Vitamin D
11. Offset weight gain in middle age with calcium supplements
Post Your Comments:
(Date:10/7/2008)...ty of life after discharge, study finds , ...edicine for intensive care unit (ICU) patients may...they,re able, a new report says. , Based on a ...ty School of Medicine researchers concluded that t...ause unnecessary and long-term physical impairment...
(Date:10/7/2008)...ely to enjoy better quality of life, study finds ,...nd-of-life discussions between a doctor and a term...for patients. In fact, they result in less aggress...life in a patient,s final days, a major new study ... has been around when, whether and how to have end...
(Date:10/7/2008)... -- Join Mii amo, a destination spa,at Enchantment...d rock,country honoring the winter solstice on Dec...al Native American ceremonies facilitated by Nativ...l guest, Elder George,Goodstriker., Goodstriker i...Reserve,in Standoff, Alberta, Canada,s largest res...
(Date:10/7/2008)...re/ -- Van Wert County Hospital, Van,Wert, Ohio, h...CARE(R),Corp.,s newest Emergency Department applic...al joins Conway Regional Medical Center, Conway,A..., Nashua, New Hampshire,in using OnRecord(TM) EDI... County Hospital began using OnRecord(TM) for all ...
Breaking Medicine News(10 mins):Health News:Early Mobility Best for ICU Patients 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Latest LOGICARE(R) EDIS User Sees 'Tremendous Results' 2
...a study published in the August issue of Neurology...ents are admitted to and discharged from the hospi...icantly. Studies have shown that several treatment...ount of disability, complications and the risk of ...
...a recent study researchers say that they found tha...te tumour cells in laboratory settings. Scientist...state cancer // could be due to a rapid increase i... the western diet in recent years. Omega-6 fats ha...
...shown that the efficacy of low-carb diets could be...chers question whether raising protein intake coul...esearchers set out to test the hypothesis that inc...bohydrate intake decreases the appetite, leads to ...
...he century started with a big bang, bringing hope ...ever, fate and nature had ideas of their own. 20...isasters and man made ones. The first internatio... February 1st in California when a jet bound for S...
Other Medicine News:Health News:Simple Procedural Improvements Can Improve Care Of Stroke Patients 2Health News:Finding The Key To Weight Loss! 2Health News:SARS (Bird Flu) spreading in the Asian continent 2
(Date:10/7/2008)...Prevented Immunologic Changes Induced by ...itional Data Indicates Potential in Treating Infla...ewswire/ -- Alba Therapeutics Corporation,presente...he American,College of Gastroenterology (ACG) 2008...001-004, the first Phase IIa trial conducted in ce...
(Date:10/7/2008)... ACG Annual Scientific Meeting -, ORLANDO, Fla., ...uticals, Inc. (formerly Microbia, Inc.) and Forest...the presentation of results from a Phase,2b study ... patients with,irritable bowel syndrome with const...at once- daily oral dosing of linaclotide, across ...
(Date:10/7/2008)...d Placebo-Controlled Phase II Study Shows ...al., MOUNTAIN VIEW, California, October 7 /PRNews...he mature Phase II data from the,therapeutic prost... been,obtained as part of the recently entered par...in the US., The results from the Phase II prospec...
(Date:10/7/2008)... /-, - 125 Patient, Prospe...,Shows Statistically Significant Improved Overall ...ature phase II data from the,therapeutic prostate ...n,obtained as part of the recently entered partner...he US., The results from the Phase II prospective...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5Cultures role on alcohol and violence 26970 1Cultures role on alcohol and violence 26970 2Forest Laboratories Inc Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings 8032 1Forest Laboratories Inc Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings 8032 2Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 1Invest in Kids Rally to Be Held Before St Louis Vice Presidential Debate 26966 2The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 1The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 2The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 3The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 4The Scientific Business of Thomson Reuters Predicts Nobel Laureates 26962 5
...ire-FirstCall/ -,Neurochem (International) Limited...em Inc. , announces that the New England,Journal o...rodisate,For AA Amyloidosis Trial" (EFAAT), recogn...r a treatment of AA amyloidosis. The,results of th...TA(TM)) demonstrate that this product candidate of...
...007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today an... evaluating the company,s once-daily,anti-HIV drug...r,DF) 300 mg as a potential treatment for chronic ... efficacy endpoint. The study shows,that Viread is...l,drug Hepsera(R) (adefovir dipivoxil) among patie...
Other Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: